3x5 Partners

What is 3x5 Partners?

3x5 Partners is a venture capital firm with a growth orientation that primarily invests in life sciences and resource-driven sectors, including software, biotechnology, retail and e-commerce, clean technology, artificial intelligence and big data, and oncology. With an operating base in Portland, Oregon, they allocate funds primarily to early-stage companies.

They have a focus on seeking out companies that act at the intersection of healthcare and climate, considering them not only as some of the world's biggest challenges but also as considerable opportunities for investment. Their investment philosophy centers on the belief that addressing healthcare and climate issues can significantly affect human well-being, while also yielding robust returns for investors.

They emphasize an "and" approach, where both healthcare and climate are addressed simultaneously, rather than prioritizing one over the other.

They look for the most innovative management teams in key sectors, such as medical devices, diagnostics, biopharmaceuticals, drug delivery systems, life science tools, clean energy, and green chemistry, to invest in solutions like clean air, food, water, shelter, education, healthcare, sanitation, and actions against climate change.

3x5 Partners has a portfolio comprising companies that engage in areas like minimally invasive surgery innovation, biomarker discovery, cancer treatment, allosteric regulation therapeutics, sustainable textiles, zinc battery technology, geothermal energy projects, and treatments for chronic venous insufficiency and lymphedema.

Their investment limits are notably specific, indicating a maximum and minimum of $100,140,000 for their commitments. Furthermore, they highlight their relationship-building prowess, which they believe is essential for venturing into early-stage investment opportunities. All their partners average over 20 years of industry experience and bring with them a dedication to fostering industry relationships that enlarge their network and assist in identifying companies with breakthrough ideas for investment.

Consolidating with American Century enhances their capacity to deliver strong results through additional resources and talent while aligning their goals with a larger commitment to fund life-changing medical research, reinforcing their shared vision of prosperity in financial endeavors as well as societal improvement.

What they say:

We are a venture capital firm.

What we look for: We invest in life sciences.